Psychiatric Genomics Consortium

The purpose of the Psychiatric Genomics Consortium (PGC) is to unite investigators around the world to conduct meta- and mega-analyses of genome-wide genomic data for psychiatric disorders. With over 800 investigators from 38 countries and samples from more than 900,000 individuals currently in analysis, the PGC is the largest consortium and the largest biological experiment in the history of psychiatry. The PGC is passionate about open, inclusive, participatory, and democratic science. Given the importance of the problems we study, we are committed to rapid progress.